Category: Disclosures

[Disclosure] Hanwha Ocean (042660) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28

June 28, 2024August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART / KOSCOM 💡 3-Second Summary This filing discloses Hanwha Ocean’s publication of its 2023 Sustainability Report, the company’s first sustainability report released since joining Hanwha Group, made available on its official website. 📊 [Key Disclosure Highlights & Summary] [Reporting Standards & Scope] [Report Content & Structure] 📝 Editor’s Comment…

Disclosures, Shipbuilding

[Disclosure] Samsung Electronics (005930) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28

June 28, 2024July 29, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics published its ‘Samsung Electronics Sustainability Report 2024’ on its official website, covering its economic, social, and environmental achievements for 2023. 📊 [Summary of Key Disclosure Details & Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Review of ESG Performance Metrics and Independent Verification Reviewing…

Semiconductors, Disclosures

[Disclosure] Hanwha Systems (272210) – Decision on Advance Payment / 2024-06-26

June 26, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has decided to make advance payments totaling KRW 85.0B to Satrec Initiative Co., Ltd. and 15 other subcontractors. 📊 [Key Disclosure Details & Financial Metrics] [Financial Summary of Representative Payee (Satrec Initiative Co., Ltd.)] (Unit: KRW Million) 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Defense

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-26

June 26, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics announced an amendment extending both the contract period end date and the non-disclosure deadline for a contract manufacturing LOI signed with a European pharmaceutical company to July 31, 2024, at the client’s request. 📊 [Key Disclosure Details & Summary Statistics] 📝 Editor’s Comment (Key…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-26

June 26, 2024August 7, 2026 K-STOCK Editor

Disclosures, Bio & Healthcare

[Disclosure] Jusung Engineering(036930) – Investor Relations (IR) Presentation / 2024-06-26

June 26, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering will hold an offline IR presentation for all shareholders on July 5, 2024, to outline its business competitiveness and corporate governance restructuring strategy, including equity spin-off and physical split. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Semiconductors, Disclosures

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-06-25

June 25, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a contract worth approximately KRW 114.8B with the Defense Acquisition Program Administration for the supply of AESA radar for KF-21 initial mass production. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Contract Performance Progress and Financial…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-06-25

June 25, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace signed a contract worth approximately KRW 556.19B with the Defense Acquisition Program Administration (DAPA) to supply engines for the initial mass production of the KF-21 fighter aircraft. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Revenue Recognition and…

Disclosures, Defense

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-25

June 25, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics announced an amendment extending the non-disclosure deadline for the counterparty of a contract manufacturing LOI signed with a U.S. pharmaceutical company to July 30, 2024, at the client’s request. 📊 [Key Disclosure Details & Summary Statistics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Tracking…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract / 2024-06-25

June 25, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics announced that it has executed a definitive contract manufacturing agreement worth approximately KRW 211.5B with Kiniksa Pharmaceuticals (UK), Ltd. 📊 [Key Disclosure Details & Summary Statistics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Main Contract Terms and Order Backlog Status in Periodic Reports…

Disclosures, Bio & Healthcare